Indication
Dilation
5 clinical trials
4 products
Product
Phentolamine MesylateClinical trial
Randomized, Parallel Arm, Double-Masked, Placebo-Controlled Study of the Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis in Healthy SubjectsStatus: Completed, Estimated PCD: 2020-12-23
Clinical trial
Randomized, Parallel Arm, Double-Masked, Placebo-Controlled Study of the Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis in Healthy SubjectsStatus: Completed, Estimated PCD: 2022-03-18
Product
PhentolamineClinical trial
Randomized, Parallel Arm, Double-Masked, Placebo-Controlled Study of the Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically Induced Mydriasis in Healthy Pediatric SubjectsStatus: Completed, Estimated PCD: 2022-04-18
Clinical trial
Randomized, Cross-Over, Double-Masked, Placebo-Controlled Study of the Safety and Efficacy of Phentolamine Mesylate Ophthalmic Solution to Reverse Pharmacologically Induced Mydriasis in Normal Healthy SubjectsStatus: Completed, Estimated PCD: 2019-09-17
Clinical trial
Efficacy of the MydCombi on Pupillary Dilation in Pediatric and Adult PatientsStatus: Not yet recruiting, Estimated PCD: 2024-12-31
Product
MydCombi